• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Clin Med . Obesity, Inflammation, and Mortality in COVID-19: An Observational Study from the Public Health Care System of New York City

tetano

Editor, Senior Moderator
J Clin Med


. 2022 Jan 26;11(3):622.
doi: 10.3390/jcm11030622.
Obesity, Inflammation, and Mortality in COVID-19: An Observational Study from the Public Health Care System of New York City


Leonidas Palaiodimos[SUP] 1 2 [/SUP], Ryad Ali[SUP] 3 [/SUP], Hugo O Teo[SUP] 1 [/SUP], Sahana Parthasarathy[SUP] 1 2 [/SUP], Dimitrios Karamanis[SUP] 3 [/SUP], Natalia Chamorro-Pareja[SUP] 1 2 [/SUP], Damianos G Kokkinidis[SUP] 1 [/SUP], Sharanjit Kaur[SUP] 1 [/SUP], Michail Kladas[SUP] 1 4 [/SUP], Jeremy Sperling[SUP] 1 2 [/SUP], Michael Chang[SUP] 1 [/SUP], Kenneth Hupart[SUP] 1 [/SUP], Colin Cha-Fong[SUP] 1 2 [/SUP], Shankar Srinivasan[SUP] 3 [/SUP], Preeti Kishore[SUP] 1 2 [/SUP], Nichola Davis[SUP] 1 5 [/SUP], Robert T Faillace[SUP] 1 2 [/SUP]



Affiliations

Abstract

Severe obesity increases the risk for negative outcomes in patients with coronavirus disease 2019 (COVID-19). Our objectives were to investigate the effect of BMI on in-hospital outcomes in our New York City Health and Hospitals' ethnically diverse population, further explore this effect by age, sex, race/ethnicity, and timing of admission, and, given the relationship between COVID-19 and hyperinflammation, assess the concentrations of markers of systemic inflammation in different BMI groups. A retrospective study was conducted in hospitalized patients with COVID-19 in the public health care system of New York City from 1 March 2020 to 31 October 2020. A total of 8833 patients were included in this analysis (women: 3593, median age: 62 years). The median body mass index (BMI) was 27.9 kg/m[SUP]2[/SUP]. Both overweight and obesity were independently associated with in-hospital death. The association of overweight and obesity with death appeared to be stronger in men, younger patients, and individuals of Hispanic ethnicity. We did not observe higher concentrations of inflammatory markers in patients with obesity as compared to those without obesity. In conclusion, overweight and obesity were independently associated with in-hospital death. Obesity was not associated with higher concentrations of inflammatory markers.

Keywords: BMI; COVID-19; New York; body mass index; mortality; obesity; observational; predictor; retrospective; risk factor.
 
Back
Top Bottom